SCHEMBL21035404

SCHEMBL21035404

CC(C)(C)OC(=O)NC1CC2CCC(C1)N2C(=O)[C@@H]1C[C@@H](Oc2ccc(Cl)cc2)CN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 4/20 0.36
MMP1 P03956 1/20 0.36
MMP3 P08254 1/20 0.36
ADAM17 P78536 1/20 0.36
MCL1 Q07820 9/20 0.36
BCL2 P10415 2/20 0.36
BCL2L1 Q07817 1/20 0.36
HTR1A P08908 2/20 0.35
HTR7 P34969 2/20 0.35
HTR5A P47898 2/20 0.35
HTR1D P28221 1/20 0.35
HTR1B P28222 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
ADRA1A P35348 1/20 0.35
HTR2B P41595 1/20 0.35
HTR6 P50406 1/20 0.35
HTR4 Q13639 1/20 0.35
MMP2 P08253 3/20 0.35
CACNB4 O00305 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035316 1.00 MMP9 (0.36) MMP9MMP1MMP3ADAM17MCL1
SCHEMBL21035667 0.94 ITGB1 (0.39) HTR1AHTR7HTR5AHTR1DHTR1B
SCHEMBL21035520 0.93 L3MBTL1 (0.39) MMP9MMP1MMP3ADAM17MCL1
SCHEMBL21035131 0.92 ITGB1 (0.38) MCL1BCL2BCL2L1HTR1AHTR7
SCHEMBL21035008 0.92 ITGB1 (0.38) MCL1BCL2BCL2L1HTR1AHTR7
SCHEMBL21034978 0.92 MCL1 (0.39) MMP9MMP3MCL1BCL2BCL2L1
SCHEMBL21035354 0.92 MCL1 (0.39) MMP9MMP3MCL1BCL2BCL2L1
SCHEMBL21035619 0.92 MMP9 (0.37) MMP9MMP1MMP3ADAM17MMP2
SCHEMBL21035077 0.90 LMNA (0.39) MMP9MMP1MMP3ADAM17HTR1A
SCHEMBL21035117 0.90 LMNA (0.39) MMP9MMP1MMP3ADAM17HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed